References
Roffman, D.S. (1984) Special concerns of digitalis use in elderly patients. Geriatrics 39(6), 97–98, 103-105.
Professional Practice in Toxicology. A Review. (1994) CME 3rd edition. University of Cincinnati (Sponsored by the American Association of Clinical Chemistry and the National Academy for Clinical Chemistry) p. 149–170.
Hager, W.D., Fenster, P. and Mayersohn, M. (1979) Digoxin-Quinidine interaction: Pharmacokinetic Evaluation. New Engl. J. Med. 300(22), 1238–1241.
Ochs, H.R., Bodem, G. and Greenbalt, D.S. (1981) Impairment of Digoxin Clearance by Coadministration of Quinidine. J. Clin. Pharmacol. 21(10), 396–400.
Njinimbam, C.C.G., Ryder, K.W., Glick, M.R., Glick, S.J. and Whang, R. (1990) Identification and treatment of Hypomagnesis and Hypokalemia in patients receiving Digoxin. Clinical Chemistry 36(3), 575–576.
Harmon, C.E. and Pontanova, J.P. (1982) Drug-induced lupus: Clinical and serological studies—Review. Clinics in Rheum. Dis. 8(1), 121–135
Mason, J.W. (1987) Amiodarone. New Engl. J. Med. 316(8), 455–466.
Podrid, J.P. (1990) Aggravation of Arrhythmia by Antiarrhythmic Drugs. In: Cardiovascular Drug Therapy. Ed. Messerli, F.H. W.B. Saunders Co., Philadelphia, USA. Ch. 95, p. 1152–1192.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nair, K.G. Clinical chemistry of anti-arrhythmic drugs. Indian J Clin Biochem 14, 95–99 (1999). https://doi.org/10.1007/BF02869154
Issue Date:
DOI: https://doi.org/10.1007/BF02869154